ABSTRACT
Periodontitis comprises a chronic inflammation that is initiated by microbiota biofilm. If left untreated, periodontitis may lead to permanent tooth loss. Herein, we propose to design and improve a localized form of therapy comprising a chlorhexidine-impregnated hydrogel. Hydrogel films were prepared by varying the ratio between cellulose (MCC) and carboxymethylcellulose sodium (CMC) using the crosslinker epichlorohydrin (ECH). The hydrogel was loaded with chlorhexidine. Increasing the CMC ratio led to a reduction in the number of pores, an increase in their size, lower glass transition temperature (T g ), decreased Young's modulus, and increased film stretching and affected the time of release. Bacterial and fungal zones of inhibition showed similar activity and were not affected by the CMC and MCC ratio. Hydrogels loaded with chlorhexidine prevented the growth of S. oralis and C. albicans microorganisms and may provide a promising local delivery system for treating periodontitis.
Subject(s)
Carboxymethylcellulose Sodium/chemistry , Chlorhexidine/therapeutic use , Methylgalactosides/therapeutic use , Periodontitis/drug therapy , Anti-Infective Agents/pharmacology , Bacteria/drug effects , Chlorhexidine/pharmacology , Drug Liberation , Elastic Modulus , Fungi/drug effects , Glass/chemistry , Humans , Kinetics , Methylgalactosides/pharmacology , Microbial Sensitivity Tests , Tensile Strength , Transition TemperatureABSTRACT
The development of hydrogel films for biomedical applications is interesting due to their characteristics. Hydrogel films based on gelatin and poly(vinyl alcohol) (PVA) are developed and characterized using a rotatable central composite design. The optimized hydrogel film is obtained by the function desirability of the Statistica® software and is also characterized by swelling kinetics, oxygen permeability, adhesiveness, TGA, DSC, and XRD. The results of the experimental design show that gelatin and PVA concentrations have a significant influence on the response variables, and the exposure doses to UV light show no significant effect. The optimized hydrogel film is elastic, presents good mechanical resistance and swelling capacity in water and exudate solution, is permeable to oxygen, and is capable of adjusting itself and maintains contact close to the skin. In this way, considering all the properties evaluated, the optimized film has characteristics suitable for biomedical applications as wound dressings.
Subject(s)
Biocompatible Materials/pharmacology , Gelatin/pharmacology , Polyvinyl Alcohol/pharmacology , Wound Healing/drug effects , Bandages , Gelatin/chemistry , Humans , Hydrogels/pharmacology , Methylgalactosides/pharmacology , Oxygen , Polyvinyl Alcohol/chemistry , Research Design , Skin , Ultraviolet RaysABSTRACT
Regenerative therapy with keratinocyte growth factor (KGF) is a novel therapeutic approach for treatment of chronic wounds. However, KGF cannot be used directly to the wound site due to its physicochemical instability. In previous study, sacran, a natural megamolecular polysaccharide, showed potential properties as a biomaterial for hydrogel film in wound healing. In this study, we fabricated sacran hydrogel film containing KGF (Sac/KGF-HF) and evaluated the effects of Sac/KGF-HF on fibroblasts migration and re-epithelialization process. We successfully prepared a homogenous and -amorphous Sac/KGF-HF by a casting method. In addition, Sac/KGF-HF had a high swelling ratio and flexibility. Sac/KGF-HF promoted a migration process of NIH3T3 cells and improved wound healing ability in mice with a percentage of wound closure reaching 90.4% at 9 d. Interestingly, the addition of KGF in Sac-HF considerably increased the number of epithelial cells compared to control, which is important in the re-epithelialization process. It could be concluded that KGF in Sac-HF has the potential for promoting Sac-HF abilities in wound healing process.
Subject(s)
Fibroblast Growth Factor 7/metabolism , Fibroblasts/drug effects , Methylgalactosides/pharmacology , Polysaccharides/pharmacology , Wound Healing/drug effects , Animals , Cell Movement/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Fibroblast Growth Factor 7/chemistry , Methylgalactosides/chemistry , Mice , Mice, Inbred BALB C , NIH 3T3 Cells , Polysaccharides/chemistryABSTRACT
In this context, we have prepared a biocompatible gelatin based polyelectrolyte hydrogel patch that has an inherent ability to self-heal in the presence of physiological pH (pHâ¯=â¯7.4). The gelatin-based hydrogel patch consists of the ionically modified self-assembled bacterial cellulose (iBC), extracted from Glucanoacetobacter xylinus (MTCC7795) bacterial strain. Presence of the iBC provides a sturdy cage to the gelatin matrix and also participates into the self-healing activity via formation of the ionic interlocking system in the presence of buffer solution having a pH of 7.4 after being damaged. The self-healing activity of the patch has been monitored through tensile strength measurement and AFM depth profilometry analyses. Loading of the curcumin in the hydrogel patch system incorporates the wound healing activity, examined over the NIH 3â¯T3 fibroblast cell line. The patch is also able to show antimicrobial activity which has been assessed via FESEM analysis and live-dead assay using propidium iodide (PI) and 4',6-diamidino-2-phenylindole (DAPI) as a fluorescent indicator. This self-healable, ionically interlocked, mechanically robust, bio-derived smart hydrogel patch system can pave a new direction in the transdermal drug delivery system.
Subject(s)
Cellulose/chemistry , Curcumin/chemistry , Gelatin/chemistry , Gluconacetobacter xylinus/chemistry , Methylgalactosides/chemistry , Methylgalactosides/pharmacology , Wound Healing/drug effects , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Chemistry Techniques, Synthetic , Drug Carriers/chemistry , Escherichia coli/drug effects , Green Chemistry Technology , Hydrogen-Ion Concentration , Mice , NIH 3T3 Cells , Staphylococcus aureus/drug effectsABSTRACT
In this study, a new kind of hemocompatible and antibacterial dual-layered polymeric membrane was fabricated by coating a top layer of graphene oxide and a sulfonated polyanion co-doped hydrogel thin film (GO-SPHF) on a bottom membrane substrate. After a two-step spin-coating of casting solutions on glass plates, dual-layered membranes were obtained by a liquid-liquid phase inversion method. The GO-SPHF composite polyethersulfone (PES) membranes (PES/GO-SPHF) showed top layers with obviously large porous structures. The chemical composition tests indicated that there were abundant hydrophilic groups enriched on the membrane surface. The examination of membrane mechanical properties indicated that the composite membranes exhibited only slightly decreased performance compared to pristine PES membranes. Moreover, to validate the potential applications of this novel dual-layered membrane in diverse fields, we tested the hemocompatibility and antibacterial activity of the membranes, respectively. Notably, the PES/GO-SPHF membranes showed highly improved in vitro hemocompatibility, such as good anti-coagulant activity, suppressed platelet adhesion and activation, low inflammation potential, and good red blood cell compatibility. Furthermore, the dual-layered membranes exhibited robust antibacterial ability after in situ loading of Ag-nanoparticles with excellent bactericidal capability to both Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). Due to the integration of the porous membrane structure, good mechanical strength, excellent hemocompatibility, as well as robust bactericidal capability, the GO and sulfonated polyanion co-doped dual-layered membranes may open up a new protocol to greatly demonstrate the potential application of polymeric membranes for clinical hemodialysis and many other biomedical therapies.
Subject(s)
Erythrocytes/drug effects , Escherichia coli/drug effects , Methylgalactosides/chemistry , Methylgalactosides/pharmacology , Oxides/chemistry , Staphylococcus aureus/drug effects , Sulfonic Acids/chemistry , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Anticoagulants/pharmacology , Graphite/chemistry , Hydrogel, Polyethylene Glycol Dimethacrylate , Oxides/pharmacology , Polyelectrolytes , Polymers/chemistry , Sulfonic Acids/pharmacologyABSTRACT
The entomopathogen Bacillus thuringiensis is equipped with multiple virulent factors. The genome sequence of B. thuringiensisâ YBT1520 revealed the presence of a two-domain protein named Nel which is composed of a necrosis-inducing phytophthora protein 1-like domain found in phytopathogens and a ricin B-like lectin domain. The merging of two distantly related domains is relatively rare. Nel induced necrosis and pathogen-triggered immunity (PTI) on model plants. The Nel also exhibited inhibition activity to nematode. Microscopic observation showed that the toxicity of Nel to nematodes targets the intestine. Quantitative proteomics revealed that Nel stimulated the host defence. The Nel thus possesses dual roles, as both toxin and elicitor. Remarkably, the Nel protein triggered a similar response, induction of the heat shock pathway and the necrosis pathway, in both model plants and nematodes. The unusual ability of Nel to function across kingdom suggests a highly conserved mechanism in eukaryotes that predates the divergence of plants and animal. It is also speculated that the two-domain protein is the result of horizontal gene transfer (HGT) between phytopathogens and entomopathogens. Our results provide an example that HGT occurs between members of different species or even genera with lower frequency are particularly important for evolution of new bacterial pathogen lineages with new virulence. Bacillus thuringiensis occupies the same ecological niches, plant and soil, as phytopathogens, providing the opportunity for gene exchange.
Subject(s)
Arabidopsis/microbiology , Bacillus thuringiensis/pathogenicity , Caenorhabditis elegans/microbiology , Heat-Shock Response/physiology , Nicotiana/microbiology , Plant Diseases/microbiology , Animals , Bacillus thuringiensis/genetics , Base Sequence , Biological Evolution , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/genetics , Gene Transfer, Horizontal , Heat-Shock Response/genetics , Methylgalactosides/pharmacology , Molecular Sequence Data , Protein Structure, Tertiary/genetics , Soil Microbiology , Virulence/geneticsABSTRACT
Corneal endothelial cells (CECs) are responsible for maintaining the transparency of the human cornea. Loss of CECs results in blindness, requiring corneal transplantation. In this study, fabrication of biocompatible and biodegradable poly(ethylene glycol) (PEG)-based hydrogel films (PHFs) for the regeneration and transplantation of CECs is described. The 50-µm thin hydrogel films have similar or greater tensile strengths to human corneal tissue. Light transmission studies reveal that the films are >98% optically transparent, while in vitro degradation studies demonstrate their biodegradation characteristics. Cell culture studies demonstrate the regeneration of sheep corneal endothelium on the PHFs. Although sheep CECs do not regenerate in vivo, these cells proliferate on the films with natural morphology and become 100% confluent within 7 d. Implantation of the PHFs into live sheep corneas demonstrates the robustness of the films for surgical purposes. Regular slit lamp examinations and histology of the cornea after 28 d following surgery reveal minimal inflammatory responses and no toxicity, indicating that the films are benign. The results of this study suggest that PHFs are excellent candidates as platforms for the regeneration and transplantation of CECs as a result of their favorable biocompatibility, degradability, mechanical, and optical properties.
Subject(s)
Biocompatible Materials/chemistry , Endothelium, Corneal/drug effects , Methylgalactosides/chemistry , Polyethylene Glycols/chemistry , Tissue Engineering/methods , Animals , Biocompatible Materials/pharmacology , Biocompatible Materials/toxicity , Cell Proliferation/drug effects , Cell Survival/drug effects , Cornea/cytology , Cornea/surgery , Endothelium, Corneal/cytology , Materials Testing , Methylgalactosides/pharmacology , Methylgalactosides/toxicity , Permeability , Polyethylene Glycols/pharmacology , Polyethylene Glycols/toxicity , Prostheses and Implants , Regeneration , Sheep , Tensile StrengthABSTRACT
Most commonly used expression systems in bacteria are based on the Escherichia coli lac promoter. Furthermore, lac operon elements are used today in systems and synthetic biology. In the majority of the cases the gratuitous inducers IPTG or TMG are used. Here we report a systematic comparison of lac promoter induction by TMG and IPTG which focuses on the aspects inducer uptake, population heterogeneity and a potential influence of the transacetylase, LacA. We provide induction curves in E. coli LJ110 and in isogenic lacY and lacA mutant strains and we show that both inducers are substrates of the lactose permease at low inducer concentrations but can also enter cells independently of lactose permease if present at higher concentrations. Using a gfp reporter strain we compared TMG and IPTG induction at single cell level and showed that bimodal induction with IPTG occurred at approximately ten-fold lower concentrations than with TMG. Furthermore, we observed that lac operon induction is influenced by the transacetylase, LacA. By comparing two Plac-gfp reporter strains with and without a lacA deletion we could show that in the lacA(+) strain the fluorescence level decreased after few hours while the fluorescence further increased in the lacA(-) strain. The results indicate that through the activity of LacA the IPTG concentration can be reduced below an inducing threshold concentration-an influence that should be considered if low inducer amounts are used.
Subject(s)
Escherichia coli/genetics , Isopropyl Thiogalactoside/pharmacology , Lac Operon/genetics , Methylgalactosides/pharmacology , Thiogalactosides/pharmacology , Acetyltransferases/genetics , Acetyltransferases/metabolism , Cell Count , Escherichia coli/drug effects , Escherichia coli/metabolism , Escherichia coli Proteins , Green Fluorescent Proteins , Lac Operon/drug effects , Microscopy, Fluorescence , Monosaccharide Transport Proteins , Protein Engineering , Recombinant Proteins , Symporters , beta-GalactosidaseABSTRACT
Methanolic extracts of six Saudi plants were screened for their in vitro antiviral activity using influenza virus A/PR/8/34 (H1N1) and MDCK cells in an MTT assay. The results indicated that the extracts of Adeniumobesum and Tephorosianubica possessed antiviral activity (99.3 and 93.3% inhibition at the concentration of 10 µg/ml, respectively). Based on these results A. obesum was selected for further study by applying bioactivity-guided fractionation to isolate its antiviral principle. The antiviral principle was isolated from the chloroform fraction through solvent fractionation, combined open liquid chromatography and HPLC. The isolated active compound A was identified as oleandrigenin-ß-D-glucosyl (1â4)-ß-D-digitalose, on the basis of its spectral analysis (MS, 1D and 2D NMR). The isolated glycoside showed reduction of virus titre by 69.3% inhibition at concentration of 1 µg/ml (IC(50)=0.86 µg/ml).
Subject(s)
Antiviral Agents/pharmacology , Apocynaceae/chemistry , Cardiac Glycosides/pharmacology , Cardiotonic Agents/pharmacology , Influenza A Virus, H1N1 Subtype/drug effects , Plant Extracts/pharmacology , Animals , Cardenolides/pharmacology , Cell Line , Chemical Fractionation , Chromatography, High Pressure Liquid , Dogs , Magnetic Resonance Spectroscopy , Methanol/chemistry , Methylgalactosides/chemistry , Methylgalactosides/isolation & purification , Methylgalactosides/pharmacology , Microbial Sensitivity Tests , Plant Components, Aerial/chemistry , Plant Extracts/chemistry , Saudi Arabia , Viral Load/drug effectsABSTRACT
We used DNA microarrays to measure transcription and iTRAQ 2D liquid chromatography-mass spectrometry/mass spectrometry (a mass-tag labeling proteomic technique) to measure protein expression in 14 strains of Escherichia coli adapted for hundreds of generations to growth-limiting concentrations of either lactulose, methylgalactoside, or a 72:28 mixture of the two. The two ancestors, TD2 and TD10, differ only in their lac operons and have similar transcription and protein expression profiles. Changes in transcription and protein expression are observed at 30-250 genes depending on the evolved strain. Lactulose specialists carry duplications of the lac operon and show increased transcription and translation at lac. Methylgalactoside specialists are galS(-) and so constitutively transcribe and translate mgl, which encodes a transporter of methylgalactoside. However, there are two strains that carry lac duplications, are galS(-), and show increased transcription and translation at both operons. One is a generalist, the other a lactulose specialist. The generalist fails to sweep to fixation because its lac(+), galS(+) competitor expresses the csg adhesin and sticks to the chemostat wall, thereby preventing complete washout. Transcription and translation are sometimes decoupled. Lactulose-adapted strains show increased protein expression at fru, a fructose transporter, without evidence of increased transcription. This suggests that fructose, produced by the action of beta-galactosidase on lactulose, may leach from cells before being recouped. Reduced expression, at "late" flagella genes and the constitutive gat operon, is an adaptation to starvation. A comparison with two other long-term evolution experiments suggests that certain aspects of adaptation are predictable, some are characteristic of an experimental system, whereas others seem erratic.
Subject(s)
Biological Evolution , Escherichia coli/classification , Escherichia coli/genetics , Protein Biosynthesis/genetics , Transcription, Genetic , Amino Acid Sequence , Analysis of Variance , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cluster Analysis , Escherichia coli/drug effects , Gene Dosage/drug effects , Gene Expression Profiling , Gene Expression Regulation, Bacterial/drug effects , Genes, Bacterial/genetics , Isotope Labeling , Lactulose/pharmacology , Methylgalactosides/pharmacology , Molecular Sequence Data , Movement/drug effects , Operon/genetics , Peptides/chemistry , Phylogeny , Protein Biosynthesis/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reproducibility of Results , Transcription, Genetic/drug effects , beta-Galactosidase/chemistry , beta-Galactosidase/genetics , beta-Galactosidase/metabolismABSTRACT
A lectin recognizing both Galbeta1-3GlcNAc and Galbeta1-4GlcNAc was purified from the demosponge Halichondria okadai by lactosyl-agarose affinity chromatography. The molecular mass of the lectin was determined to be 30 kDa by SDS-PAGE under reducing and non-reducing conditions and 60 kDa by gel permeation chromatography. The pI value of the lectin was 6.7. It was found to agglutinate trypsinized and glutaraldehyde-fixed rabbit and human erythrocytes in the presence and absence of divalent cations. The hemagglutinating activity by the lectin was inhibited by d-galactose, methyl-d-galactopyranoside, N-acetyl-d-galactosamine, methyl-N-acetyl-d-galactosaminide, lactose, melibiose, and asialofetuin. The K(d) of the lectin against p-nitrophenyl-beta-lactoside was determined to be 2.76x10(-5) M and its glycan-binding profile given by frontal affinity chromatography was shown to be similar to many other known galectins. Partial primary structure analysis of 7 peptides by cleavage with lysyl endopeptidase indicated that one of the peptides showed significant similarity with galectin purified from the sponge Geodia cydonium.
Subject(s)
Galectins/isolation & purification , Galectins/metabolism , Porifera/metabolism , Acetylgalactosamine/pharmacology , Animals , Asialoglycoproteins/pharmacology , Carbohydrate Sequence , Cations, Divalent/pharmacology , Chromatography, Affinity , Dansyl Compounds/pharmacology , Electrophoresis, Polyacrylamide Gel , Fetuins , Galactosamine/analogs & derivatives , Galactosamine/pharmacology , Galactose/pharmacology , Galectins/pharmacology , Glycosides/metabolism , Hemagglutination/drug effects , Humans , Isoelectric Focusing , Lactose/pharmacology , Melibiose/pharmacology , Methylgalactosides/pharmacology , Molecular Sequence Data , Rabbits , alpha-Fetoproteins/pharmacologyABSTRACT
A combination of microplate technology and turbidity assessment for testing the adherence of P-fimbriated Escherichia coli to human uroepithelial cell line T24, validated with the addition of the known inhibitor 4-O-alpha-D-galactopyranosyl-alpha-D-galactopyranose (galabiose), resulted in a high-throughput, biologically relevant assessment of cranberry (Vaccinium macrocarpon). P-fimbriated ATCC E. coli strains 25922, 29194, and 49161 were inhibited by galabiose. ATCC 29194, a representative urine isolate containing the papGII allele (Class II fimbrial adhesin) and demonstrating the most significant inhibition in the presence of galabiose, was chosen for further testing. In this assay, a low-polarity fraction of cranberry juice cocktail demonstrated dose-dependent inhibition of E. coli adherence. Reported here, for the first time in V. macrocarpon, are 1-O-methylgalactose, prunin, and phlorizin, identified in an active fraction of cranberry juice concentrate. This in vitro assay will be useful for the standardization of cranberry dietary supplements and is currently being used for bioassay-guided fractionation of cranberry juice concentrate.
Subject(s)
Bacterial Adhesion/drug effects , Beverages/analysis , Escherichia coli/physiology , Fruit/chemistry , Urinary Tract Infections/microbiology , Vaccinium macrocarpon/chemistry , Cell Line , Epithelial Cells , Escherichia coli/classification , Escherichia coli/drug effects , Humans , Methylgalactosides/isolation & purification , Methylgalactosides/pharmacology , Phlorhizin/analogs & derivatives , Phlorhizin/isolation & purification , Phlorhizin/pharmacology , Urinary TractABSTRACT
The development of pest resistance threatens the effectiveness of Bacillus thuringiensis (Bt) toxins used in transgenic and organic farming. Here, we demonstrate that (i) the major mechanism for Bt toxin resistance in Caenorhabditis elegans entails a loss of glycolipid carbohydrates; (ii) Bt toxin directly and specifically binds glycolipids; and (iii) this binding is carbohydrate-dependent and relevant for toxin action in vivo. These carbohydrates contain the arthroseries core conserved in insects and nematodes but lacking in vertebrates. We present evidence that insect glycolipids are also receptors for Bt toxin.
Subject(s)
Bacterial Proteins/metabolism , Bacterial Toxins/metabolism , Caenorhabditis elegans/metabolism , Endotoxins/metabolism , Glycosphingolipids/metabolism , Animals , Bacillus thuringiensis Toxins , Bacterial Proteins/toxicity , Bacterial Toxins/toxicity , Binding Sites , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/genetics , Caenorhabditis elegans Proteins/metabolism , Endotoxins/toxicity , Galactose/pharmacology , Glycolipids/chemistry , Glycolipids/isolation & purification , Glycolipids/metabolism , Glycosphingolipids/chemistry , Glycosphingolipids/isolation & purification , Glycosyltransferases/genetics , Glycosyltransferases/metabolism , Hemolysin Proteins , Insecticide Resistance , Lipid Bilayers , Methylgalactosides/metabolism , Methylgalactosides/pharmacology , Methylglucosides/metabolism , Methylglucosides/pharmacology , Monosaccharides/analysis , MutationABSTRACT
Melibiose carrier mutants, isolated by growing cells on melibiose plus the non-metabolizable competitive inhibitor thiomethyl-beta-galactoside (TMG), were studied to determine sugar and cation recognition abnormalities. Most of the mutants show good transport of melibiose but have lost the recognition of TMG. In addition, most mutants show little or no transport of lactose. Cation recognition is also affected as all of these mutants have lost the ability to transport protons with melibiose. The amino acids causing these mutations were determined by sequencing the melB gene on the plasmid. The mutations were located on helices I, IV, VII, X and XI. We propose that these five helices are in proximity with each other and that they line the sugar/cation transport channel.
Subject(s)
Escherichia coli/genetics , Membrane Transport Proteins/genetics , Symporters , Binding Sites , Binding, Competitive , Biological Transport , Carbohydrate Metabolism , Cations , Cell Membrane/enzymology , Drug Resistance , Escherichia coli/enzymology , Melibiose/metabolism , Membrane Transport Modulators , Membrane Transport Proteins/antagonists & inhibitors , Membrane Transport Proteins/metabolism , Methylgalactosides/pharmacology , Mutation , Protein Conformation , Proton Pumps , Sodium/metabolism , Thiogalactosides/pharmacologyABSTRACT
The selective binding of serum amyloid P component (SAP) to proteins in the pathological amyloid cross-beta fold suggests a possible chaperone role. Here we show that human SAP enhances the refolding yield of denatured lactate dehydrogenase and protects against enzyme inactivation during agitation of dilute solutions. These effects are independent of calcium ions and are not inhibited by compounds that block the amyloid recognition site on the B face of SAP, implicating the A face and/or the edges of the SAP pentamer. We discuss the possibility that the chaperone property of SAP, or its failure, may contribute to the pathogenesis of amyloidosis.
Subject(s)
Molecular Chaperones/pharmacology , Serum Amyloid P-Component/pharmacology , Binding Sites , Binding, Competitive , C-Reactive Protein/pharmacology , Calcium/metabolism , Calcium/pharmacology , Deoxyadenine Nucleotides/pharmacology , Enzyme Reactivators/pharmacology , Enzyme Stability/drug effects , Humans , L-Lactate Dehydrogenase/chemistry , L-Lactate Dehydrogenase/drug effects , L-Lactate Dehydrogenase/metabolism , Methylgalactosides/metabolism , Methylgalactosides/pharmacology , Molecular Chaperones/chemistry , Molecular Chaperones/metabolism , Protein Denaturation , Protein Folding , Serum Amyloid P-Component/chemistry , Serum Amyloid P-Component/metabolismABSTRACT
To improve the structural organization model of melibiose permease, we assessed the individual contributions of the N-terminal tryptophans to the transporter fluorescence variations induced by the binding of cations and beta-configured sugars, by replacement of the six N-terminal tryptophans by phenylalanines and the study of the signal changes. Only two mutations, W116F located in helix IV and W128F located in the cytoplasmic loop 4-5, impair permease activity. The intrinsic fluorescence spectroscopy analysis of the other mutants suggests that W54, located in helix II, W116, and W128 are mostly responsible for the cation-induced fluorescence variations. These tryptophans, W116 and W128, would also be responsible for the beta-galactoside-induced fluorescence changes observed in the N-terminal domain of the transporter. The implication of W116 and W128 in both the cation- and beta-galactoside-induced fluorescence variations led us to investigate in detail the effects of their mutations on the functional properties of the permease. The results obtained suggest that the domains harboring the two tryptophans, or the residues themselves, play a critical role in the mechanism of Na(+)/sugar symport. Taken together, the results presented in this paper and previous results are consistent with a fundamental role of helix IV in connecting cation- and sugar-binding sites of the melibiose permease.
Subject(s)
Carbohydrate Metabolism , Cations, Monovalent/metabolism , Escherichia coli/enzymology , Membrane Transport Proteins/chemistry , Membrane Transport Proteins/metabolism , Symporters , Amino Acid Substitution/genetics , Binding Sites , Biological Transport/drug effects , Carbohydrates/pharmacology , Cations, Monovalent/pharmacology , Kinetics , Melibiose/metabolism , Membrane Transport Proteins/genetics , Methylgalactosides/metabolism , Methylgalactosides/pharmacology , Models, Molecular , Mutation/genetics , Nitrophenylgalactosides/metabolism , Osmolar Concentration , Protein Structure, Secondary , Protein Structure, Tertiary , Proteolipids/drug effects , Proteolipids/metabolism , Raffinose/metabolism , Raffinose/pharmacology , Sodium/metabolism , Sodium/pharmacology , Spectrometry, Fluorescence , Substrate Specificity , Thiogalactosides/metabolism , Thiogalactosides/pharmacology , Tryptophan/genetics , Tryptophan/metabolism , Tyrosine/genetics , Tyrosine/metabolismABSTRACT
Poor transfection efficiency of human lung carcinoma cells by lipofection begs further development of more efficient gene delivery strategies. The purpose of this study was to determine whether lectins can improve the lipofection efficiency in lung carcinoma cells. A549, Calu3, and H292 cells grown to 90% confluence were transfected for 18 h with a plasmid DNA containing a beta-galactosidase reporter gene (pCMVlacZ) using lipofectin plus a lectin as the vector. Ten different lectins, which exhibit a wide range of carbohydrate-binding specificities, were examined for their abilities to enhance the efficiency of lipofection. The transfected cells were assessed for transfection efficiency by beta-galactosidase activity (units/microg protein) and % blue cells following X-Gal stain. Lipofectin supplemented with Griffonia simplicifolia-I (GS-I) yields largest enhancement of the lipofection efficiency in A549 and Calu3 cells (5.3- and 28-fold, respectively). Maackia amurensis gives the largest enhancement (6.5-fold) of lipofection efficiency in H292 cells. The transfection efficiency correlates with the amounts of DNA delivered to the nucleus. Binding of FITC-labeled GS-I and the enhancement of the lipofection efficiency by GS-I were inhibited by alpha-methyl-D-galactopyranoside, indicating an alpha-galactoside-mediated gene transfer to lung carcinoma cells. We conclude that lectin-facilitated lipofection is an efficient gene delivery strategy. Employment of cell type-specific lectins may allow for efficient cell type-specific gene targeting.
Subject(s)
Lectins/administration & dosage , Lung Neoplasms/genetics , Plant Lectins , Transfection/methods , Humans , Lectins/antagonists & inhibitors , Liposomes , Methylgalactosides/pharmacology , Tumor Cells, CulturedABSTRACT
Binding of the coupling ion (Na+ or Li+) and sugars to the purified melibiose permease of Escherichia coli, reconstituted in proteoliposomes, produces selective and cooperative changes of the transporter tryptophan fluorescence. To assess the individual contribution of N- or C-terminal domains of the permease to these substrate-induced fluorescence variations, we replaced the two tryptophans located in its C-terminal half (W299 and W342) by a phenylalanine and compared the signal change in mutants and wild-type permease. None of the mutations significantly impairs transport activity. Persistence of the ion-induced signal quenching in a permease carrying only the six other tryptophans of the N-terminal domain is consistent with a previous suggestion that this domain accommodates the ion-binding site. On the other hand, the sugar-induced fluorescence increase varies from mutant to mutant in a sugar-specific fashion. While alpha-galactosides increase essentially the fluorescence of W299 and W342, beta-galactosides enhance the signal of W299 and of one (or more) of the N-terminal tryptophans but quench that of W342. Moreover, addition of sugars producers a 10 nm blue shift of both W299 and W342 emission spectra, suggesting reduced accessibility of these residues to solvent following substrate binding. These data suggest that W299 and W342 are at or close to the sugar binding site and that this latter is lined by the C-terminal helices IX and X. Moreover, as sugars with the beta-configuration also enhance the fluorescence of the N-terminal tryptophans, it is suggested that one (or more) helix of the N-terminal half may be also at or near the sugar binding site. This implies close proximity and/or tight functional linkage between some N-terminal helices and helices IX and X of the C-terminal domain of the transporter.
Subject(s)
Escherichia coli/enzymology , Membrane Transport Proteins/chemistry , Membrane Transport Proteins/metabolism , Protein Structure, Secondary , Symporters , Amino Acid Sequence , Binding Sites , Kinetics , Liposomes , Melibiose/pharmacology , Methylgalactosides/pharmacology , Models, Structural , Molecular Sequence Data , Mutagenesis, Site-Directed , Point Mutation , Proteolipids/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Spectrometry, Fluorescence , Thiogalactosides/pharmacology , TryptophanABSTRACT
Elements of the lactose operon were used to study parameters affecting gene expression in cultured cells and transgenic animals. A Lac repressor protein containing a nuclear transport signal was shown to inhibit expression of a reporter gene by interacting with lac operator sequences. In cultured cells, operator sequence, operator placement and induction parameters were all shown to be important for obtaining tight repression of a reporter gene followed by high level expression upon induction. Induction levels were also dependent on the reporter gene, with the luciferase gene yielding higher induction levels than the chloramphenicol acetyltransferase gene. In transgenic animals, the lacI mRNA was not detected in the C57BL/6 mouse strain until the animal was exposed to a demethylating agent. After 5-azacytidine treatment, expression of lacI mRNA was detected in the brain, heart, kidney, lung and ovary. In the FVB transgenic mouse strain, expression of lacI mRNA was detected without 5-azacytidine treatment in the kidney, liver, lung, and testes. Preliminary experiments with double transgenic animals containing both lacI and operator/luciferase transgenes showed a decrease in luciferase expression compared to the luciferase-only animals in both tissue extracts and transgenic fetal primary cultures, although IPTG induction was not achieved in these animals or primary cultures. The applicability and challenges of the system for regulation of gene expression are discussed.
Subject(s)
Bacterial Proteins/biosynthesis , Bacterial Proteins/genetics , Escherichia coli Proteins , Genetic Vectors/genetics , Mice, Transgenic/genetics , Repressor Proteins/biosynthesis , Repressor Proteins/genetics , Animals , Bacterial Proteins/drug effects , Base Sequence , Cell Nucleus/genetics , Cell Nucleus/metabolism , Cells, Cultured , Chloramphenicol O-Acetyltransferase/genetics , Chloramphenicol O-Acetyltransferase/metabolism , Cloning, Molecular/methods , Dose-Response Relationship, Drug , Eukaryotic Cells , Female , Fetus/cytology , Fetus/metabolism , Gene Expression Regulation , Genes, Reporter , Genetic Vectors/metabolism , Isopropyl Thiogalactoside/pharmacology , Lac Repressors , Male , Methylation , Methylgalactosides/pharmacology , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Molecular Sequence Data , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Repressor Proteins/drug effects , Thiogalactosides/pharmacology , Time Factors , Tissue DistributionABSTRACT
Mycoplasma penetrans isolated from clinical specimens of AIDS patients showed potent activity in tumor necrosis factor alpha (TNF alpha) production in THP-1, U937 and J22HL60 cell lines, and in the enhancement of HIV-1 replication in a dormantly-infected J22HL60 cell line as compared with the activities of other mycoplasmas. Both activities were found in the methanol layer but not in the chloroform layer of the membrane extracted by the Bligh-Dyer method. TNF alpha production was observed in the peritoneal macrophages from both lipopolysaccharide-responsive and -unresponsive mouse strains, and was not inhibited by polymyxin B. The induction of TNF alpha production and enhancement of HIV-1 replication were strongly inhibited by Concanavalin A-Sepharose. The inhibitory effect of Concanavalin A-Sepharose was partially prevented by sugars in the order methyl-alpha-D-mannopyranoside and methyl-alpha-D-glucopyranoside but not methyl-alpha-D-galactopyranoside. Anti-human TNF alpha antibody, however, did not reduce the activity of the methanol layer to enhance HIV-1 replication, suggesting that the methanol layer could enhance HIV-1 replication directly. These results suggest that the carbohydrate derived from M. penetrans might be responsible for the progression of HIV-1 infection.